XML 69 R55.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
12 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis The Company's assets measured at estimated fair value on a recurring basis at September 30, 2025 and 2024 are as follows (dollars in thousands):
 Estimated Fair Value
September 30, 2025Level 1Level 2Level 3Total
Available for sale investment securities    
      U.S. government securities$4,968 $— $— $4,968 
MBS: U.S. government agencies
— 73,272 — 73,272 
Investments in equity securities
Mutual funds
864 — — 864 
Total$5,832 $73,272 $ $79,104 

September 30, 2024
Available for sale investment securities    
     U.S. government securities$3,939 $— $— $3,939 
     MBS: U.S. government agencies— 68,318 — 68,318 
Investments in equity securities
     Mutual funds866 — — 866 
Total$4,805 $68,318 $ $73,123 
Balances of Assets Measured at Estimated Fair Value, Nonrecurring Basis
The following table summarizes the balances of assets measured at estimated fair value on a non-recurring basis at September 30, 2025 and 2024 (dollars in thousands):

Total EstimatedEstimated Fair Value Measurements Using
Fair ValueLevel 1Level 2Level 3
September 30, 2025
Individually evaluated collateral-dependent loans
   Commercial business loans$177 $— $— $177 
          Total loans177 — — 177 
OREO and other repossessed assets221 — — 221 
Total$398 $— $— $398 
September 30, 2024
Individually evaluated collateral-dependent loans$1,315 $— $— $1,315 
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques
The following table presents quantitative information about Level 3 inputs for financial instruments measured at fair value on a non-recurring basis at September 30, 2025 and 2024:

Valuation TechniqueSignificant Unobservable InputsRange
Individually evaluated collateral-dependent loans Market approachAppraised value less estimated selling costs8%
OREO and other repossessed assetsMarket approachLower of appraised value or listing price less estimated selling costs8%
Balances of Assets and Liabilities Measured at Estimated Fair Value, Recurring Basis
The recorded amounts and estimated fair values of financial instruments were as follows as of September 30, 2025 (dollars in thousands):
  Fair Value Measurements Using:
  Recorded
Amount
Estimated Fair Value Level 1Level 2 Level 3
Financial Assets     
Cash and cash equivalents$243,428 $243,428 $243,428 $— $— 
CDs held for investment7,217 7,217 7,217 — — 
Investment securities215,101 210,574 71,870 138,704 — 
Investments in equity securities864 864 864 — — 
FHLB stock2,045 2,045 2,045 — — 
Other investments3,000 3,000 3,000 — — 
Loans held for sale1,127 1,159 1,159 — — 
Loans receivable, net1,463,590 1,441,850 — — 1,441,850 
Accrued interest receivable7,393 7,393 7,393 — — 
Financial Liabilities     
Certificates of deposit
442,521 442,024 — — 442,024 
FHLB borrowings20,000 20,009 — — 20,009 
Accrued interest payable1,963 1,963 1,963 — — 

The recorded amounts and estimated fair values of financial instruments were as follows as of September 30, 2024 (dollars in thousands):
  Fair Value Measurements Using:
  Recorded
Amount
Estimated Fair Value Level 1Level 2 Level 3
Financial Assets     
Cash and cash equivalents$164,728 $164,728 $164,728 $— $— 
CDs held for investment10,209 10,209 10,209 — — 
Investment securities244,354 238,264 92,124 146,140 — 
Investments in equity securities 866 866 866 — — 
FHLB stock2,037 2,037 2,037 — — 
Other investments3,000 3,000 3,000 — — 
Loans receivable, net1,421,523 1,387,642 — — 1,387,642 
Accrued interest receivable6,990 6,990 6,990 — — 
Financial Liabilities     
Certificates of deposit
368,308 368,312 — — 368,312 
FHLB borrowings20,000 20,035 — — 20,035 
Accrued interest payable2,132 2,132 2,132 — —